Anxiety News and Research

Latest Anxiety News and Research

Consumption of medications for treatment of insomnia or anxiety increases mortality risk

Taking medications to treat insomnia and anxiety increases mortality risk by 36%, according to a study conducted by Genevi-ve Belleville, a professor at Universit- Laval's School of Psychology. The details of this study are published in the latest edition of the Canadian Journal of Psychiatry.

9 Sep 2010

'Revenge of the Introverts' addresses new research

The work of West Virginia author and psychologist Laurie Helgoe of Charleston is the cover story in the latest issue of the national magazine, Psychology Today.

8 Sep 2010

Health law rollout effects: Delivering 'accountable' care, device tax, nursing mothers

Today's updates on the continuing implementation of the health law include Medicare chief Don Berwick's behind the scenes push for 'accountable care organizations,' tax anxiety in the medical device industry, and the promise of new help for pregnant women.

8 Sep 2010

DTC consumers express concern on personal genetic risk test

One half of people using direct to consumer (DTC) personal genetic risk tests express concerns about testing yet more than 80 percent want to know their risk even for non preventable genetic diseases, according to a study in the September Genetics in Medicine, the official peer reviewed journal of The American College of Medical Genetics (ACMG).

8 Sep 2010

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).

7 Sep 2010

Hallucinogen psilocybin safe for administration in patients with advanced-stage cancer and anxiety: Study

A pilot study suggests the hallucinogen psilocybin may be feasible and safe to administer to patients with advanced-stage cancer and anxiety, with promising effects on mood, according to a report published online today that will appear in the January 2011 print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

7 Sep 2010

Psilocybin reduces anxiety, improves mood with advanced-stage cancer: Study

In the first human study of its kind to be published in more than 35 years, researchers found psilocybin, an hallucinogen which occurs naturally in "magic mushrooms," can safely improve the moods of patients with advanced-stage cancer and anxiety, according to an article published online today in the Archives of General Psychiatry.

7 Sep 2010

Study finds acupuncture can control side effects of cancer treatment

Recent studies have shown that acupuncture can help control a number of symptoms and side effects such as pain, fatigue, dry mouth, nausea, and vomiting associated with a variety of cancers and their treatments.

3 Sep 2010

Researchers recommend health care organizations invest in time and resources for LSAEs disclosure

Health care organizations should disclose medical mistakes that affect multiple patients even if patients were not harmed by the event, according to an AHRQ-funded research paper published in the September 2 issue of the New England Journal of Medicine.

3 Sep 2010

Health care organizations should disclose medical errors that affect multiple patients: Researchers

3 Sep 2010

TCC gears up early intervention programs for families, children with autistic spectrum disorders

In preparation for the new school year The Children's Center's is gearing up their early intervention programs for families and children with autistic spectrum disorders between the ages 18 months to 6 years old. The Children's Center recognizes one of the fastest growing developmental disability in the United States affecting our children is Autism. That's why TCC is offering back to school support to families of children with autism spectrum disorder.

3 Sep 2010

PCOS Challenge creates television series to help women with Polycystic Ovarian Syndrome

In an effort to bring greater awareness to Polycystic Ovarian Syndrome, PCOS Challenge, Inc. has created a 13-week television series to help women with PCOS. PCOS is estimated to affect one-in-ten women of childbearing age. It can lead to other serious conditions including endometrial cancer, obesity, diabetes and infertility.

3 Sep 2010

BAP releases new guidelines on treatments for sleep disorders

Insomnia and other sleep disorders are very common, yet are not generally well understood by doctors and other health care professionals. Now the British Association for Psychopharmacology (BAP) has released up-to-the-minute guidelines in the Journal of Psychopharmacology, published by SAGE, to guide psychiatrists and physicians caring for those with sleep problems.

3 Sep 2010

European Commission approves MSD's MAA for SYCREST in manic episodes associated with bipolar I disorder

MSD announced today that the European Commission has approved the Marketing Authorization Application (MAA) for SYCREST® (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. Today's decision was based on recommendations from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The Commission Decision applies to all 27 European Member States.

3 Sep 2010

Lack of sleep linked to depression and anxiety disorders in young

According to Australian research, youngsters getting inadequate sleep are at risk of mental ailments. Researcher Nicholas Glozier of the University of Sydney said, the increase in incidence of mental ailments in the young has been puzzling health experts. The answer may lie in inadequate sleep.

2 Sep 2010

Mindfulness training increases well-being in adolescents, reports new study

'Mindfulness', the process of learning to become more aware of our ongoing experiences, increases well-being in adolescent boys, a new study reports. Researchers from the University of Cambridge analyzed 155 boys from two independent UK schools, Tonbridge and Hampton, before and after a four-week crash course in mindfulness. After the trial period, the 14 and 15 year-old boys were found to have increased well-being, defined as the combination of feeling good (including positive emotions such as happiness, contentment, interest and affection) and functioning well.

2 Sep 2010

Researcher awarded $1.8M grant to investigate sex differences in anxiety

Anxiety disorders afflict women twice as often as men, but estrogen might not be the reason. Testosterone, though, could be. That is one of the preliminary findings in the lab of Florida State University researcher Mohamed Kabbaj, associate professor in the College of Medicine. He recently was awarded a five-year, $1.8 million grant from the National Institute of Mental Health to investigate the sex differences in anxiety.

2 Sep 2010

Anxiety in school is seasonal and age dependent: Pediatric psychiatrists

With summer fading, anxiety is on the rise for some students anticipating the return of school. But it isn't just the first days of classes that can provoke angst -- anxiety in school is seasonal and age dependent, say pediatric psychiatrists.

2 Sep 2010

GP training may accelerate improvement in physical functioning for patients with somatoform disorder

In this pragmatic cluster-randomised controlled trial the investigators aimed to test the effect of a training programme for general practitioners (GPs) in the treatment of functional somatic symptoms (FSS). Results indicate that GP training may accelerate improvement in physical functioning for patients with somatoform disorder. However, the effect is small and may not be clinically significant.

31 Aug 2010

Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list for depression treatment

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover's list of the "Top 10 Most Interesting Neuroscience Projects to Watch."

31 Aug 2010

Anxiety News and Research

Latest Anxiety News and Research

Consumption of medications for treatment of insomnia or anxiety increases mortality risk

'Revenge of the Introverts' addresses new research

Health law rollout effects: Delivering 'accountable' care, device tax, nursing mothers

DTC consumers express concern on personal genetic risk test

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

Hallucinogen psilocybin safe for administration in patients with advanced-stage cancer and anxiety: Study

Psilocybin reduces anxiety, improves mood with advanced-stage cancer: Study

Study finds acupuncture can control side effects of cancer treatment

Researchers recommend health care organizations invest in time and resources for LSAEs disclosure

Health care organizations should disclose medical errors that affect multiple patients: Researchers

TCC gears up early intervention programs for families, children with autistic spectrum disorders

PCOS Challenge creates television series to help women with Polycystic Ovarian Syndrome

BAP releases new guidelines on treatments for sleep disorders

European Commission approves MSD's MAA for SYCREST in manic episodes associated with bipolar I disorder

Lack of sleep linked to depression and anxiety disorders in young

Mindfulness training increases well-being in adolescents, reports new study

Researcher awarded $1.8M grant to investigate sex differences in anxiety

Anxiety in school is seasonal and age dependent: Pediatric psychiatrists

GP training may accelerate improvement in physical functioning for patients with somatoform disorder

Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list for depression treatment

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Anxiety News and Research

Latest Anxiety News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in